Skip to main content

Table 2 Meta-regression of covariates on prevalence of SAO

From: Spirometry parameters used to define small airways obstruction in population-based studies: systematic review

 

Coefficient (% change in prevalence)

95% CI

p value

Spirometry parameter

 FEF25–75

(Ref)

–

–

 FEF25–75/VC

− 14.3

− 38.6, 10.0

0.250

 FEF50/FEF25

9.7

5.9, 13.4

< 0.001

 FEV3/FVC

− 5.7

− 9.3, − 2.1

0.002

 FEF50

− 19.3

− 23.1, − 15.6

< 0.001

WHO region

 Americas

(ref)

–

–

 European

24.3

3.0, 45.6

0.025

 Western Pacific

5.3

3.0, 7.5

< 0.001

 South East Asia

4.1

− 18.7, 26.9

0.726

  1. p < 0.05 = significant. FEF25–75: Mean expiratory flow rate between 25 and 75% of the FVC, FEF25–75/VC: Mean expiratory flow rate between 25 and 75% of the FVC as a ratio of the vital capacity. FEF50: Forced expiratory flow rate at 50% of the FVC. FEF50/FEF25: Forced expiratory flow at 50% of the FVC as a ratio or the forced expiratory flow with 25% of the FVC remaining, FEV3/FVC: forced expiratory volume in 3 s as a ratio of the FVC